25 XP   0   0   10

Lincoln Pharmaceuticals Limited
Buy, Hold or Sell?

Let's analyse Lincoln Pharmaceuticals Limited together

PenkeI guess you are interested in Lincoln Pharmaceuticals Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lincoln Pharmaceuticals Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lincoln Pharmaceuticals Limited

I send you an email if I find something interesting about Lincoln Pharmaceuticals Limited.

Quick analysis of Lincoln Pharmaceuticals Limited (30 sec.)










What can you expect buying and holding a share of Lincoln Pharmaceuticals Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.07
When do you have the money?
1 year
How often do you get paid?
90.0%

What is your share worth?

Current worth
INR250.86
Expected worth in 1 year
INR389.85
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR144.99
Return On Investment
24.8%

For what price can you sell your share?

Current Price per Share
INR585.40
Expected price per share
INR532.25 - INR754.25
How sure are you?
50%

1. Valuation of Lincoln Pharmaceuticals Limited (5 min.)




Live pricePrice per Share (EOD)

INR585.40

Intrinsic Value Per Share

INR-121.23 - INR225.89

Total Value Per Share

INR129.64 - INR476.75

2. Growth of Lincoln Pharmaceuticals Limited (5 min.)




Is Lincoln Pharmaceuticals Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$60.2m$51.9m$8.3m13.9%

How much money is Lincoln Pharmaceuticals Limited making?

Current yearPrevious yearGrowGrow %
Making money$8.7m$8.3m$425.3k4.9%
Net Profit Margin14.3%14.7%--

How much money comes from the company's main activities?

3. Financial Health of Lincoln Pharmaceuticals Limited (5 min.)




4. Comparing to competitors in the Drug Manufacturers - Major industry (5 min.)




  Industry Rankings (Drug Manufacturers - Major)  

What can you expect buying and holding a share of Lincoln Pharmaceuticals Limited? (5 min.)

Welcome investor! Lincoln Pharmaceuticals Limited's management wants to use your money to grow the business. In return you get a share of Lincoln Pharmaceuticals Limited.

What can you expect buying and holding a share of Lincoln Pharmaceuticals Limited?

First you should know what it really means to hold a share of Lincoln Pharmaceuticals Limited. And how you can make/lose money.

Speculation

The Price per Share of Lincoln Pharmaceuticals Limited is INR585.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lincoln Pharmaceuticals Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lincoln Pharmaceuticals Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR250.86. Based on the TTM, the Book Value Change Per Share is INR34.75 per quarter. Based on the YOY, the Book Value Change Per Share is INR28.47 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR1.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lincoln Pharmaceuticals Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.440.1%0.440.1%0.420.1%0.370.1%0.250.0%
Usd Book Value Change Per Share0.420.1%0.420.1%0.340.1%0.330.1%0.300.1%
Usd Dividend Per Share0.020.0%0.020.0%0.020.0%0.020.0%0.020.0%
Usd Total Gains Per Share0.430.1%0.430.1%0.360.1%0.350.1%0.320.1%
Usd Price Per Share4.06-4.06-3.73-2.93-2.33-
Price to Earnings Ratio9.31-9.31-8.98-7.89-9.99-
Price-to-Total Gains Ratio9.34-9.34-10.38-8.18-8.54-
Price to Book Ratio1.35-1.35-1.44-1.28-1.51-
Price-to-Total Gains Ratio9.34-9.34-10.38-8.18-8.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.0248
Number of shares142
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share0.420.33
Usd Total Gains Per Share0.430.35
Gains per Quarter (142 shares)61.7650.16
Gains per Year (142 shares)247.06200.63
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11023723711189191
22047448423378392
33171173134567593
44194797846757794
5511184122557946995
661142114726911351196
772165817198013241397
882189519669215131598
9922132221310317021799
101022368246011518922000

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%
Dividend per Share1.00.00.0100.0%2.00.01.066.7%4.00.01.080.0%9.00.01.090.0%9.00.01.090.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%10.00.00.0100.0%

Fundamentals of Lincoln Pharmaceuticals Limited

About Lincoln Pharmaceuticals Limited

Lincoln Pharmaceuticals Limited manufactures and sells pharmaceutical products in India and internationally. It offers products in the areas of anti-infective, respiratory system, gynecology, cardio and CNS, anti-bacterial, ant-diabetic, anti-malaria, and others areas. The company also trades in pharmaceutical products. Lincoln Pharmaceuticals Limited was founded in 1979 and is based in Ahmedabad, India.

Fundamental data was last updated by Penke on 2024-03-26 11:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Lincoln Pharmaceuticals Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lincoln Pharmaceuticals Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A Net Profit Margin of 14.3% means that ₹0.14 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 14.3%. The company is making a huge profit. +2
  • The TTM is 14.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.3%0.0%
TTM14.3%YOY14.7%-0.4%
TTM14.3%5Y14.1%+0.2%
5Y14.1%10Y10.4%+3.6%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%10.6%+3.7%
TTM14.3%10.6%+3.7%
YOY14.7%13.3%+1.4%
5Y14.1%10.2%+3.9%
10Y10.4%10.1%+0.3%
1.1.2. Return on Assets

Shows how efficient Lincoln Pharmaceuticals Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • 12.4% Return on Assets means that Lincoln Pharmaceuticals Limited generated ₹0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 12.4%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 12.4%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ12.4%TTM12.4%0.0%
TTM12.4%YOY13.0%-0.6%
TTM12.4%5Y13.1%-0.7%
5Y13.1%10Y10.3%+2.8%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ12.4%8.3%+4.1%
TTM12.4%8.3%+4.1%
YOY13.0%9.5%+3.5%
5Y13.1%9.7%+3.4%
10Y10.3%8.3%+2.0%
1.1.3. Return on Equity

Shows how efficient Lincoln Pharmaceuticals Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • 14.5% Return on Equity means Lincoln Pharmaceuticals Limited generated ₹0.15 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 14.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 14.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ14.5%TTM14.5%0.0%
TTM14.5%YOY16.0%-1.5%
TTM14.5%5Y16.3%-1.8%
5Y16.3%10Y15.2%+1.1%
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ14.5%12.6%+1.9%
TTM14.5%12.6%+1.9%
YOY16.0%12.3%+3.7%
5Y16.3%16.3%+0.0%
10Y15.2%13.7%+1.5%

1.2. Operating Efficiency of Lincoln Pharmaceuticals Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lincoln Pharmaceuticals Limited is operating .

  • Measures how much profit Lincoln Pharmaceuticals Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y7.9%-7.9%
5Y7.9%10Y9.2%-1.3%
1.2.2. Operating Ratio

Measures how efficient Lincoln Pharmaceuticals Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • An Operation Ratio of 0.50 means that the operating costs are ₹0.50 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.496. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.496. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.496TTM0.4960.000
TTM0.496YOY0.483+0.013
TTM0.4965Y0.813-0.317
5Y0.81310Y1.175-0.361
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4960.497-0.001
TTM0.4960.497-0.001
YOY0.4830.469+0.014
5Y0.8130.813+0.000
10Y1.1751.171+0.004

1.3. Liquidity of Lincoln Pharmaceuticals Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lincoln Pharmaceuticals Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A Current Ratio of 5.08 means the company has ₹5.08 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 5.080. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.080. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.080TTM5.0800.000
TTM5.080YOY3.899+1.181
TTM5.0805Y3.911+1.169
5Y3.91110Y2.778+1.133
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0802.176+2.904
TTM5.0802.176+2.904
YOY3.8992.121+1.778
5Y3.9111.911+2.000
10Y2.7781.566+1.212
1.3.2. Quick Ratio

Measures if Lincoln Pharmaceuticals Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A Quick Ratio of 4.72 means the company can pay off ₹4.72 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 4.725. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.725. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.725TTM4.7250.000
TTM4.725YOY3.627+1.098
TTM4.7255Y3.347+1.378
5Y3.34710Y2.235+1.112
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ4.7251.584+3.141
TTM4.7251.584+3.141
YOY3.6271.767+1.860
5Y3.3471.430+1.917
10Y2.2351.030+1.205

1.4. Solvency of Lincoln Pharmaceuticals Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lincoln Pharmaceuticals Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lincoln Pharmaceuticals Limited to Drug Manufacturers - Major industry mean.
  • A Debt to Asset Ratio of 0.14 means that Lincoln Pharmaceuticals Limited assets are financed with 14.5% credit (debt) and the remaining percentage (100% - 14.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.145. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.145. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.145TTM0.1450.000
TTM0.145YOY0.190-0.045
TTM0.1455Y0.196-0.051
5Y0.19610Y0.334-0.139
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1450.402-0.257
TTM0.1450.402-0.257
YOY0.1900.403-0.213
5Y0.1960.433-0.237
10Y0.3340.486-0.152
1.4.2. Debt to Equity Ratio

Measures if Lincoln Pharmaceuticals Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A Debt to Equity ratio of 16.9% means that company has ₹0.17 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lincoln Pharmaceuticals Limited:

  • The MRQ is 0.169. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.169. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.169TTM0.1690.000
TTM0.169YOY0.234-0.065
TTM0.1695Y0.246-0.077
5Y0.24610Y0.617-0.371
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1690.516-0.347
TTM0.1690.516-0.347
YOY0.2340.556-0.322
5Y0.2460.588-0.342
10Y0.6170.857-0.240

2. Market Valuation of Lincoln Pharmaceuticals Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Lincoln Pharmaceuticals Limited generates.

  • Above 15 is considered overpriced but always compare Lincoln Pharmaceuticals Limited to the Drug Manufacturers - Major industry mean.
  • A PE ratio of 9.31 means the investor is paying ₹9.31 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lincoln Pharmaceuticals Limited:

  • The EOD is 16.084. Based on the earnings, the company is fair priced.
  • The MRQ is 9.306. Based on the earnings, the company is underpriced. +1
  • The TTM is 9.306. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD16.084MRQ9.306+6.778
MRQ9.306TTM9.3060.000
TTM9.306YOY8.983+0.323
TTM9.3065Y7.888+1.418
5Y7.88810Y9.992-2.104
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD16.08416.860-0.776
MRQ9.30610.473-1.167
TTM9.30610.473-1.167
YOY8.98313.672-4.689
5Y7.8889.785-1.897
10Y9.9929.9920.000
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lincoln Pharmaceuticals Limited:

  • The EOD is 46.939. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 27.158. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 27.158. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD46.939MRQ27.158+19.781
MRQ27.158TTM27.1580.000
TTM27.158YOY20.356+6.802
TTM27.1585Y14.021+13.137
5Y14.02110Y31.032-17.010
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD46.93947.529-0.590
MRQ27.15817.381+9.777
TTM27.15817.381+9.777
YOY20.35620.3560.000
5Y14.02114.021+0.000
10Y31.0326.307+24.725
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lincoln Pharmaceuticals Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Major industry mean).
  • A PB ratio of 1.35 means the investor is paying ₹1.35 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Lincoln Pharmaceuticals Limited:

  • The EOD is 2.334. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.350. Based on the equity, the company is underpriced. +1
  • The TTM is 1.350. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.334MRQ1.350+0.983
MRQ1.350TTM1.3500.000
TTM1.350YOY1.439-0.089
TTM1.3505Y1.284+0.066
5Y1.28410Y1.512-0.228
Compared to industry (Drug Manufacturers - Major)
PeriodCompanyIndustry (mean)+/- 
EOD2.3342.363-0.029
MRQ1.3501.350+0.000
TTM1.3501.350+0.000
YOY1.4391.439+0.000
5Y1.2841.472-0.188
10Y1.5122.335-0.823
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lincoln Pharmaceuticals Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--34.74734.7470%28.471+22%27.751+25%25.086+39%
Book Value Per Share--250.864250.8640%216.117+16%189.169+33%133.431+88%
Current Ratio--5.0805.0800%3.899+30%3.911+30%2.778+83%
Debt To Asset Ratio--0.1450.1450%0.190-24%0.196-26%0.334-57%
Debt To Equity Ratio--0.1690.1690%0.234-28%0.246-31%0.617-73%
Dividend Per Share--1.5001.5000%1.498+0%1.685-11%1.297+16%
Eps--36.39636.3960%34.626+5%30.442+20%20.826+75%
Free Cash Flow Per Share--12.47112.4710%15.281-18%22.165-44%13.911-10%
Free Cash Flow To Equity Per Share--10.22410.2240%14.005-27%13.534-24%6.742+52%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--225.889--------
Intrinsic Value_10Y_min---121.227--------
Intrinsic Value_1Y_max--22.317--------
Intrinsic Value_1Y_min--11.516--------
Intrinsic Value_3Y_max--67.296--------
Intrinsic Value_3Y_min--14.310--------
Intrinsic Value_5Y_max--112.569--------
Intrinsic Value_5Y_min---5.155--------
Market Cap11708000000.000+42%6784069551.0006784069551.0000%6230247516.500+9%4887063413.500+39%3890631706.750+74%
Net Profit Margin--0.1430.1430%0.147-3%0.141+2%0.104+37%
Operating Margin----0%-0%0.079-100%0.092-100%
Operating Ratio--0.4960.4960%0.483+3%0.813-39%1.175-58%
Pb Ratio2.334+42%1.3501.3500%1.439-6%1.284+5%1.512-11%
Pe Ratio16.084+42%9.3069.3060%8.983+4%7.888+18%9.992-7%
Price Per Share585.400+42%338.700338.7000%311.050+9%244.160+39%194.435+74%
Price To Free Cash Flow Ratio46.939+42%27.15827.1580%20.356+33%14.021+94%31.032-12%
Price To Total Gains Ratio16.150+42%9.3449.3440%10.379-10%8.184+14%8.537+9%
Quick Ratio--4.7254.7250%3.627+30%3.347+41%2.235+111%
Return On Assets--0.1240.1240%0.130-4%0.131-5%0.103+20%
Return On Equity--0.1450.1450%0.160-9%0.163-11%0.152-5%
Total Gains Per Share--36.24736.2470%29.969+21%29.436+23%26.383+37%
Usd Book Value--60296928.00060296928.0000%51945288.000+16%45433855.200+33%32040126.533+88%
Usd Book Value Change Per Share--0.4170.4170%0.342+22%0.333+25%0.301+39%
Usd Book Value Per Share--3.0103.0100%2.593+16%2.270+33%1.601+88%
Usd Dividend Per Share--0.0180.0180%0.018+0%0.020-11%0.016+16%
Usd Eps--0.4370.4370%0.416+5%0.365+20%0.250+75%
Usd Free Cash Flow--2997588.0002997588.0000%3672828.000-18%5321699.280-44%3339724.680-10%
Usd Free Cash Flow Per Share--0.1500.1500%0.183-18%0.266-44%0.167-10%
Usd Free Cash Flow To Equity Per Share--0.1230.1230%0.168-27%0.162-24%0.081+52%
Usd Market Cap140496000.000+42%81408834.61281408834.6120%74762970.198+9%58644760.962+39%46687580.481+74%
Usd Price Per Share7.025+42%4.0644.0640%3.733+9%2.930+39%2.333+74%
Usd Profit--8747916.0008747916.0000%8322612.000+5%7311054.240+20%5000665.510+75%
Usd Revenue--61237056.00061237056.0000%56654796.000+8%51822938.928+18%45158088.678+36%
Usd Total Gains Per Share--0.4350.4350%0.360+21%0.353+23%0.317+37%
 EOD+4 -4MRQTTM+0 -0YOY+21 -135Y+21 -1410Y+29 -6

3.2. Fundamental Score

Let's check the fundamental score of Lincoln Pharmaceuticals Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.084
Price to Book Ratio (EOD)Between0-12.334
Net Profit Margin (MRQ)Greater than00.143
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than14.725
Current Ratio (MRQ)Greater than15.080
Debt to Asset Ratio (MRQ)Less than10.145
Debt to Equity Ratio (MRQ)Less than10.169
Return on Equity (MRQ)Greater than0.150.145
Return on Assets (MRQ)Greater than0.050.124
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Lincoln Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.219
Ma 20Greater thanMa 50618.198
Ma 50Greater thanMa 100646.986
Ma 100Greater thanMa 200636.822
OpenGreater thanClose596.850
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets5,874,202
Total Liabilities849,458
Total Stockholder Equity5,024,744
 As reported
Total Liabilities 849,458
Total Stockholder Equity+ 5,024,744
Total Assets = 5,874,202

Assets

Total Assets5,874,202
Total Current Assets3,672,128
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 224,930
Short-term Investments 913,526
Net Receivables 1,363,308
Inventory 700,279
Other Current Assets 194,369
Total Current Assets  (as reported)3,672,128
Total Current Assets  (calculated)3,396,412
+/- 275,716
Long-term Assets
Property Plant Equipment 1,569,475
Intangible Assets 2,946
Long-term Assets  (as reported)0
Long-term Assets  (calculated)1,572,421
+/- 1,572,421

Liabilities & Shareholders' Equity

Total Current Liabilities722,841
Long-term Liabilities0
Total Stockholder Equity5,024,744
Total Current Liabilities
Short-term Debt 19,972
Total Current Liabilities  (as reported)722,841
Total Current Liabilities  (calculated)19,972
+/- 702,869
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock200,297
Retained Earnings 4,183,057
Capital Surplus 646,166
Other Stockholders Equity -4,776
Total Stockholder Equity (as reported)5,024,744
Total Stockholder Equity (calculated)5,024,744
+/-0
Other
Cash And Equivalents292,676
Cash and Short Term Investments 1,138,456
Common Stock Shares Outstanding 20,030
Liabilities and Stockholders Equity 5,874,202
Net Working Capital 2,949,287



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-31
> Total Assets 
2,597,555
2,580,285
2,757,221
3,053,394
3,472,351
3,659,849
3,893,878
4,593,717
5,343,572
5,874,202
5,874,2025,343,5724,593,7173,893,8783,659,8493,472,3513,053,3942,757,2212,580,2852,597,555
   > Total Current Assets 
1,490,630
1,773,856
1,476,552
1,810,494
2,183,362
2,240,422
2,479,971
3,064,559
3,528,495
3,672,128
3,672,1283,528,4953,064,5592,479,9712,240,4222,183,3621,810,4941,476,5521,773,8561,490,630
       Cash And Cash Equivalents 
104,514
115,094
92,299
85,612
80,194
21,197
23,509
114,384
183,156
224,930
224,930183,156114,38423,50921,19780,19485,61292,299115,094104,514
       Short-term Investments 
0
0
0
102,000
171,115
181,009
181,009
807,478
969,609
913,526
913,526969,609807,478181,009181,009171,115102,000000
       Net Receivables 
1,020,763
1,264,118
797,597
906,695
1,094,408
1,224,694
1,013,359
1,113,275
1,159,413
1,363,308
1,363,3081,159,4131,113,2751,013,3591,224,6941,094,408906,695797,5971,264,1181,020,763
       Inventory 
238,410
218,184
274,819
373,060
454,115
362,257
473,960
466,127
727,420
700,279
700,279727,420466,127473,960362,257454,115373,060274,819218,184238,410
       Other Current Assets 
126,943
176,460
268,323
300,610
378,874
345,233
344,456
200,803
125,779
194,369
194,369125,779200,803344,456345,233378,874300,610268,323176,460126,943
   > Long-term Assets 
0
0
0
1,283,080
1,288,989
1,444,394
1,419,427
0
0
0
0001,419,4271,444,3941,288,9891,283,080000
       Property Plant Equipment 
627,959
628,854
913,388
997,413
1,073,055
1,133,529
1,131,656
1,119,260
1,475,516
1,569,475
1,569,4751,475,5161,119,2601,131,6561,133,5291,073,055997,413913,388628,854627,959
       Goodwill 
41,430
48,006
92,256
92,256
92,256
92,256
92,256
92,256
0
0
0092,25692,25692,25692,25692,25692,25648,00641,430
       Long Term Investments 
4,057
55
55
55
0
0
0
0
0
0
0000005555554,057
       Intangible Assets 
5,060
4,814
2,557
3,749
3,355
4,241
3,694
3,981
3,827
2,946
2,9463,8273,9813,6944,2413,3553,7492,5574,8145,060
> Total Liabilities 
1,572,377
1,437,910
1,321,470
1,129,545
1,230,171
966,403
762,989
840,797
1,014,798
849,458
849,4581,014,798840,797762,989966,4031,230,1711,129,5451,321,4701,437,9101,572,377
   > Total Current Liabilities 
1,310,531
1,106,528
1,047,687
908,869
1,049,348
853,362
655,826
735,455
904,862
722,841
722,841904,862735,455655,826853,3621,049,348908,8691,047,6871,106,5281,310,531
       Short-term Debt 
681,365
764,840
524,044
450,441
485,471
300,935
38,332
0
20,436
19,972
19,97220,436038,332300,935485,471450,441524,044764,840681,365
       Short Long Term Debt 
681,365
764,840
780,456
655,123
543,594
319,165
319,165
0
0
0
000319,165319,165543,594655,123780,456764,840681,365
       Accounts payable 
665,100
453,082
303,771
270,424
434,164
440,146
512,426
0
0
0
000512,426440,146434,164270,424303,771453,082665,100
       Other Current Liabilities 
74,750
76,308
51,591
36,297
55,234
43,211
69,295
0
0
0
00069,29543,21155,23436,29751,59176,30874,750
   > Long-term Liabilities 
0
0
0
301,058
177,558
109,457
109,489
0
0
0
000109,489109,457177,558301,058000
       Long term Debt Total 
0
0
194,353
123,836
69,269
16,921
8,489
1,445
0
0
001,4458,48916,92169,269123,836194,35300
       Long-term Liabilities Other 
0
0
0
34,619
0
0
0
0
0
0
00000034,619000
> Total Stockholder Equity
988,124
1,113,112
1,435,751
1,923,849
2,242,180
2,693,446
3,130,889
3,752,920
4,328,774
5,024,744
5,024,7444,328,7743,752,9203,130,8892,693,4462,242,1801,923,8491,435,7511,113,112988,124
   Common Stock
163,108
163,108
163,108
200,000
200,000
200,000
200,000
200,000
200,297
200,297
200,297200,297200,000200,000200,000200,000200,000163,108163,108163,108
   Retained Earnings 
440,972
565,960
1,272,643
1,723,849
2,042,180
2,493,446
2,930,889
2,909,843
3,484,109
4,183,057
4,183,0573,484,1092,909,8432,930,8892,493,4462,042,1801,723,8491,272,643565,960440,972
   Capital Surplus 
0
0
0
0
0
646,166
646,166
646,166
646,166
646,166
646,166646,166646,166646,166646,16600000
   Treasury Stock0000000000
   Other Stockholders Equity 
3,500
3,500
79,129
3,500
4,498
4,830
215
-3,089
-1,798
-4,776
-4,776-1,798-3,0892154,8304,4983,50079,1293,5003,500



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue5,103,088
Cost of Revenue-2,533,419
Gross Profit2,569,6692,569,669
 
Operating Income (+$)
Gross Profit2,569,669
Operating Expense-0
Operating Income805,4692,569,669
 
Operating Expense (+$)
Research Development0
Selling General Administrative1,672,374
Selling And Marketing Expenses0
Operating Expense01,672,374
 
Net Interest Income (+$)
Interest Income205,815
Interest Expense-0
Other Finance Cost-205,815
Net Interest Income0
 
Pretax Income (+$)
Operating Income805,469
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,004,798805,469
EBIT - interestExpense = 0
728,993
728,993
Interest Expense0
Earnings Before Interest and Taxes (EBIT)01,004,798
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,004,798
Tax Provision-275,805
Net Income From Continuing Ops0728,993
Net Income728,993
Net Income Applicable To Common Shares728,993
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net00
 

Technical Analysis of Lincoln Pharmaceuticals Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lincoln Pharmaceuticals Limited. The general trend of Lincoln Pharmaceuticals Limited is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lincoln Pharmaceuticals Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lincoln Pharmaceuticals Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 623.65 < 754.25.

The bearish price targets are: 558.10 > 533.95 > 532.25.

Tweet this
Lincoln Pharmaceuticals Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lincoln Pharmaceuticals Limited. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lincoln Pharmaceuticals Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lincoln Pharmaceuticals Limited. The current macd is -18.4881524.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lincoln Pharmaceuticals Limited price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lincoln Pharmaceuticals Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lincoln Pharmaceuticals Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Lincoln Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) ChartLincoln Pharmaceuticals Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lincoln Pharmaceuticals Limited. The current adx is 21.84.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Lincoln Pharmaceuticals Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Lincoln Pharmaceuticals Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lincoln Pharmaceuticals Limited. The current sar is 616.66.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lincoln Pharmaceuticals Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lincoln Pharmaceuticals Limited. The current rsi is 39.22. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Lincoln Pharmaceuticals Limited Daily Relative Strength Index (RSI) ChartLincoln Pharmaceuticals Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lincoln Pharmaceuticals Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Lincoln Pharmaceuticals Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Lincoln Pharmaceuticals Limited Daily Stochastic Oscillator ChartLincoln Pharmaceuticals Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lincoln Pharmaceuticals Limited. The current cci is -61.36395363.

Lincoln Pharmaceuticals Limited Daily Commodity Channel Index (CCI) ChartLincoln Pharmaceuticals Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lincoln Pharmaceuticals Limited. The current cmo is -24.59038875.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lincoln Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) ChartLincoln Pharmaceuticals Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lincoln Pharmaceuticals Limited. The current willr is -72.9300942.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lincoln Pharmaceuticals Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Lincoln Pharmaceuticals Limited Daily Williams %R ChartLincoln Pharmaceuticals Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lincoln Pharmaceuticals Limited.

Lincoln Pharmaceuticals Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lincoln Pharmaceuticals Limited. The current atr is 25.86.

Lincoln Pharmaceuticals Limited Daily Average True Range (ATR) ChartLincoln Pharmaceuticals Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lincoln Pharmaceuticals Limited. The current obv is 781,406.

Lincoln Pharmaceuticals Limited Daily On-Balance Volume (OBV) ChartLincoln Pharmaceuticals Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lincoln Pharmaceuticals Limited. The current mfi is 40.16.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Lincoln Pharmaceuticals Limited Daily Money Flow Index (MFI) ChartLincoln Pharmaceuticals Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lincoln Pharmaceuticals Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-13BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Lincoln Pharmaceuticals Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lincoln Pharmaceuticals Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.219
Ma 20Greater thanMa 50618.198
Ma 50Greater thanMa 100646.986
Ma 100Greater thanMa 200636.822
OpenGreater thanClose596.850
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lincoln Pharmaceuticals Limited with someone you think should read this too:
  • Are you bullish or bearish on Lincoln Pharmaceuticals Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lincoln Pharmaceuticals Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lincoln Pharmaceuticals Limited

I send you an email if I find something interesting about Lincoln Pharmaceuticals Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Lincoln Pharmaceuticals Limited.

Receive notifications about Lincoln Pharmaceuticals Limited in your mailbox!